# Ashish M. Kamat

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ashish-m-kamat/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,718 |
| Field | Bladder and Urothelial Cancer Treatments |
| h-index | 89 |
| i10-index | 384 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5034005227 |
| ORCID iD | https://orcid.org/0000-0003-3546-9928 |
| Works | 1,074 |

## Researcher papers

- [Anti-CTLA-4 therapy results in higher CD4 <sup>+</sup> ICOS <sup>hi</sup> T cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues](https://scholariq.org/papers/anti-ctla-4-therapy-results-in-higher-cd4-sup-sup-icos-sup-hi-sup-t-cell/)
- [EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†](https://scholariq.org/papers/eau-esmo-consensus-statements-on-the-management-of-advanced-and-variant-bladder/)

## Researcher topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Urinary and Genital Oncology Studies](https://scholariq.org/topics/urinary-and-genital-oncology-studies-2/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Urological Disorders and Treatments](https://scholariq.org/topics/urological-disorders-and-treatments-2/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.